My Profession Has Been Wrong About Neuropathy For 25 Years — And I'm Going On Record.

What a diabetes educator taught me in a hospital cafeteria.

February 2024. I was on a rotation at a rural clinic in central Texas. During a lunch break I ended up next to a 62-year-old certified diabetes educator — a woman who'd worked for four decades in nutrition-based nerve rehab. I mentioned, off-hand, that I'd been prescribing gabapentin to 40% of my new-patient consults and it was doing almost nothing. She set her fork down and said, quietly, "You're a neurologist. You should know it's not their blood sugar."

Then she asked me one question that undid twenty years of my medical training. I'll get to that question in a moment. First I need to tell you the three things happening in your peripheral nerves right now, so you understand why nothing your GP has recommended has worked.

Three things happening in your nerves — right now.

One. It's not the blood sugar. It's a damaged myelin sheath.

Peripheral neuropathy is myelin damage — the fatty insulation around your small nerves has been oxidised and stripped. Blood sugar is one of many things that damages it, but B-vitamin deficiency, chronic inflammation, and low antioxidant capacity are equally common causes. That's why 78% of adults with diagnosable neuropathy have no diabetes at all.

Two. Gabapentin and pregabalin don't repair — they mask.

The prescriptions your GP writes for tingling feet are GABA-modulators. They dial down the pain signal in your brain. They do nothing to repair the damaged nerve — they just make you notice less. Which is why patients quietly lose motor function on them.

Three. Standard multivitamins don't fix the deficiency.

The B1 (thiamine) and B12 in every over-the-counter multivitamin are the cheap synthetic forms. Thiamine HCl is water-soluble and gets flushed. Cyanocobalamin has to be converted — a process that gets worse as you age. So even people who "take a multi" are B-vitamin deficient at the tissue level. That's the gap.

Which is why the answer, when I finally found it, wasn't a prescription or a multivitamin. It was three specific compounds — dosed at clinical levels — delivered as a daily softgel that rebuilds nerve myelin from the inside. Bear with me.

Her question was: "Why aren't you rebuilding the myelin?"

I laughed. Politely. The educator across the table was not offended — she simply pulled up three studies on her phone. A 2019 meta-analysis of 15 alpha-lipoic-acid RCTs: ALA 600mg/day for 12 weeks produced a 71% clinically meaningful reduction in the Total Symptom Score for painful diabetic neuropathy. A 2022 replication with benfotiamine (the fat-soluble B1): symptom score dropped 40% at 6 weeks, absorption 5x cyanocobalamin. A 2020 review in Nutrients: sub-clinical B12 deficiency present in 40%+ of chronic-neuropathy patients over 50.

The mechanism is obvious once you see it. ALA is the universal antioxidant that quenches the oxidative stress destroying myelin. Benfotiamine rebuilds the thiamine-dependent enzymes the myelin needs to reform. Methylcobalamin B12 is the direct cofactor for myelin synthesis. Three targets. One stack.

She looked at me and said, "The reason your profession doesn't teach this is that you can't sell a softgel for the price of a $400 script."

The four things I insisted on when I built the softgel.

I went home, sourced clinical-grade R-Alpha-Lipoic-Acid, benfotiamine, and methylcobalamin B12, formulated them into a bovine-gelatin softgel dosed at the levels the RCTs actually used, and gave it to seven of my neuropathy patients for 12 weeks. By week eight, five of the seven reported reduction in the tingling of at least a 4 on the 0-10 scale. By week twelve, three had returned to walking without shoes on grass.

I refined the formula for another six months with two colleagues. We now call it Neurolign. Here's what I insisted on:

1. ALA at 600mg per serving. Below the studied dose you don't get symptom reduction. Most drugstore ALA caps at 300mg.
2. Benfotiamine, not thiamine HCl. Benfotiamine is fat-soluble and 5x more bioavailable. Every drugstore B-complex uses cheap thiamine HCl.
3. Methylcobalamin B12, not cyanocobalamin. Methylcobalamin is the pre-activated form your neurons can use immediately. Cyanocobalamin has to be converted.
4. No fillers. No dyes. No artificial anything. Three actives — ALA, benfotiamine, methylcobalamin — inside a bovine-gelatin softgel. That's the whole product.

Who this is for.

Neurolign is for adults over 45 who have had tingling, burning, or numbness in their feet or hands for three months or longer, with or without a diabetes diagnosis, and would rather try a food-grade nutrient stack for eight weeks than start a gabapentin script. It is not for people with active chemotherapy, insulin-dependent Type 1 diabetes with unstable blood sugar, or a known ALA sensitivity. If any of those describe you, do not buy this — see a specialist.

If none of those describe you, and you've been quietly hiding your feet under socks in summer for a year or two, know this: your small nerves have not "given up." Their myelin is oxidised — actively degrading — but they are capable of remyelination when given the three specific inputs they run low on.

What today's Neurolign bundle includes.

A single amber-glass bottle of 60 daily softgels — a 30-day loading-dose supply or a 60-day maintenance supply — plus three digital bonuses I personally wrote for our patients:

• The 12-Week Nerve-Reset Field Manual — the daily protocol I use with my patients ($29 value)
• The 3-Day Nerve-Circulation Primer — the movement + soak routine that complements systemic delivery ($19 value)
• Your Dedicated Coach — email support from our clinical team for 60 days ($29 value)

Total stack value: $136. Today's price: $59. And if it doesn't work — if within 60 days you don't feel a meaningful drop in tingling — you email us and get every dollar refunded. Keep the bonuses.